Structurally Conserved Interaction of Lgl Family with SNAREs Is Critical to Their Cellular Function  by Gangar, Akanksha et al.
Current Biology, Vol. 15, 1136–1142, June 21, 2005, ©2005 Elsevier Ltd All rights reserved. DOI 10.1016/j.cub.2005.05.046
Structurally Conserved Interaction of Lgl Family
with SNAREs Is Critical to Their Cellular FunctionAkanksha Gangar,1 Guendalina Rossi,
Anna Andreeva, Robert Hales,
and Patrick Brennwald*
Department of Cell and Developmental Biology
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina 27599
Summary
The Lethal giant larvae (Lgl) tumor suppressor family
is conserved from yeast to mammals and plays a criti-
cal yet controversial role in cell polarity. Studies on
Drosophila Lgl suggest that its function in polarity is
through regulation of the acto-myosin cytoskeleton.
In contrast, studies on the yeast Lgl homologs, Sro7/
Sro77, suggest a function in exocytosis through in-
teraction with the t-SNARE Sec9. Using yeast/mam-
malian Lgl chimeras, we demonstrate that the overall
architecture of Lgl proteins is highly conserved and
that the C-terminal domain is the major site of SNARE
interaction within both yeast and mammalian homo-
logs. Importantly, we find that the ability of Lgl chime-
ras to function as the only source of Lgl in yeast cor-
relates precisely with the ability to interact with the
yeast t-SNARE. We report a novel interaction between
Sro7 and the yeast myosin V, Myo2. However, we find
that interactions with either Myo2 or Myo1 (myosin II)
cannot account for the dramatic functional differ-
ences observed for these chimeras in yeast. These
results provide the first demonstration that the in-
teraction of an Lgl family member with a specific ef-
fector is critical to its function in vivo. These data
support the model that the Lgl family functions in cell
polarity, at least in part, by regulating SNARE-medi-
ated membrane delivery events at the cell surface.
Results and Discussion
Chimeric Lgl Proteins Implicate the C-terminal
Domain in Determining the Specificity
of SNARE Binding
To determine the region within Sro7 involved in binding
to the t-SNARE Sec9, we compared full-length Sro7 to
the Sro7 C-terminal domain in their ability to bind to
recombinant full-length Sec9. The results shown in Fig-
ure 1A demonstrate that whereas 14% of the in vitro
translated Sro7-CT protein bound to GST-Sec9, 90% of
the full-length Sro7 was bound to Sec9. Binding assays
with the Sro7 N-terminal WD domain showed no de-
tectable binding to Sec9 (A.G. and P.B., unpublished
data). Previous work from our lab has shown that
whereas the C-terminal half of Sro7 was capable of
binding in vitro to Sec9, only full-length Sro7 was capa-
ble of interacting with Sec9 in an in vivo assay [1]. This*Correspondence: pjbrennw@med.unc.edu
1Present address: Molecular Pharmacology, UMR599 INSERM-
Institut Paoli-Calmettes, 13009 Marseille, France.suggests that although the C-terminal domain of Sro7
is competent for binding to the t-SNARE Sec9, its abil-
ity to bind in vitro (and in vivo) is dramatically enhanced
by the presence of the N-terminal WD40 repeat domain.
Our finding that mammalian Mlgl-1 interacts with the
mammalian t-SNARE Syntaxin 4 suggests that SNARE
interaction is a conserved property of the members of
this family [2]. In order to examine the SNARE binding
capacity and specificity of Sro7/Lgl family proteins, we
investigated whether Sro7 and Mlgl-1 interact with the
heterologous t-SNAREs (i.e., Sro7 with Syntaxin 4 and
Mlgl-1 with Sec9). Not surprisingly, given the evolution-
ary distance between yeast and mammals, the noncog-
nate pairs of proteins did not interact (Figure 1D). We
made use of this specificity to extend the domain
analysis by constructing chimeric molecules, in which
the N-terminal WD repeats of the yeast and mammalian
proteins were reciprocally exchanged (Figure 1B). This
allowed us to examine the SNARE binding activity of
each domain in the context of the full-length protein.
This swap produced two chimeric proteins: Sro71–525/
Mlgl463–1034 (referred to as the S/M chimera) and
Mlgl1–462/Sro7526–1033 (M/S chimera) (Figure 1B). Each
chimeric protein was in vitro translated and bound to
a panel of recombinant SNARE proteins to assess its
binding properties (Figures 1C and 1D). Remarkably, we
find that the binding of the M/S chimera to Sec9 was
nearly identical to that of wild-type full-length Sro7 (Fig-
ure 1D). Like Sro7, the M/S chimera showed the strong-
est interaction with full-length Sec9. A slight interaction
of the M/S chimera with Syntaxin 4 was also observed.
Conversely, the S/M chimera demonstrated a clear
preference for Syntaxin 4, although a weak interaction
with Sec9 was also detected (Figure 1D). These find-
ings demonstrate that the specificity of the Lgl-SNARE
interaction resides largely in the C-terminal domain of
the Lgl family. Although the N terminus of Sro7/Lgl ap-
pears to have a structural role in potentiating the overall
affinity of the interaction with t-SNAREs, it has only a
minor role in determining its specificity. These data pro-
vide strong evidence that the C-terminal domain of the
Lgl family has a critical role in mediating the specific
interaction with SNARE proteins in both yeast and
mammalian cells.
We next determined the ability of each of the chime-
ras to function in vivo as the only source of Sro7/Lgl.
Wild-type and chimeric sequences were introduced
into yeast on both single-copy (CEN) and multicopy
(2) vectors under the control of the SRO7 promoter,
and their expression levels were monitored by quantita-
tive immunoblot analysis with antisera specific to the N
and C termini of Sro7 or the C terminus of Mlgl-1. As
expected, the expression level of SRO7 from a CEN
plasmid was identical to that from the chromosomal lo-
cus (data not shown); each of the chimeric proteins was
also expressed, although at a lower level (Figure 2A).
When the chimeras were introduced on multicopy (2)
vectors, their expression improved considerably: Quan-
titative immunoblot experiments revealed that each of
Cellular Role of Lgl
1137Figure 1. Lgl Family of Proteins Interacts with Their Cognate Plasma Membrane SNARE via the C-Terminal Domain In Vitro
(A) Binding of Sro7-CT and Sro7-FL proteins to GST-Sec9. Sro7-CT and Sro7-FL were in vitro transcribed and translated with rabbit reticulate
lysate in the presence of [35S]methionine. The radiolabeled proteins were incubated with 2 M GST or GST-Sec9 immobilized on beads. After
several washes, bound and unbound samples were analyzed by SDS-PAGE and autoradiography and quantitated with Storm PhosphorImager.
The percentages of in vitro translated proteins bound to GST-Sec9 are indicated.
(B) Schematic representations of domain structure of Sro7 and Mlgl-1 and chimeras used in this study. The conserved WD repeat domain in
Sro7 and Mlgl-1 is shown as hatched.
(C) Coomassie staining of the GST-SNARE recombinant proteins used in the in vitro binding assays.
(D) Binding of Sro7, Mlgl-1, or chimeric proteins to GST-SNARE fusion proteins. Sro7, Mlgl-1, and the chimeras were in vitro transcribed and
translated with rabbit reticulate lysate in the presence of [35S]methionine and incubated with various GST fusions proteins (2 M). Bindings
were performed as described in the Experimental Procedures. The percentages of in vitro translated proteins bound to GST-SNAREs are indi-
cated.the chimeras was expressed at levels that were roughly
similar (2-fold higher) to that of single-copy Sro7.
The critical test of function for the Sro7/Lgl chimeras
is their ability to rescue the severe cold-sensitive
growth and secretion defects that are manifest in the
sro7D,sro77D mutant. Figure 2B demonstrates that
when expressed from a high-copy 2 plasmid, the M/S
chimera is able to suppress the cold-sensitive pheno-
type of this mutant, nearly as strongly as wild-type Sro7
(Figure 2B). When present on a CEN plasmid, the M/S
chimera is a weak suppressor of the sro7D,sro77D mu-
tant (Figure 2B). In contrast, the S/M chimera was un-
able to suppress the cold sensitivity of this strain, even
when expressed at levels similar to those of the M/S
chimera (Figure 2B). We also examined the ability of
these chimeras to suppress the post-Golgi secretory
defect associated with loss of chromosomal SRO7 and
SRO77 genes by taking advantage of the Bgl2 secre-
tion assay [3]. Bgl2 is a cell-wall endoglucanase whose
delivery to the cell surface depends on the intact secre-tory pathway [4]. Defect in the normal transport of Bgl2
manifests itself as an increase in the internal pool of
this protein in relation to the extracellular pool. We
found that strains containing empty vector or 2 plas-
mids expressing Mlgl-1 and S/M proteins all had a pro-
nounced defect in the secretion of Bgl2 protein (Figure
2C). In each case, the secretion defect was markedly
exacerbated by a shift to low temperature. In contrast,
in strains expressing Sro7 from a CEN plasmid and the
M/S chimera from a 2 plasmid (which results in similar
levels of each protein), the secretory function was re-
stored both at permissive and restrictive conditions
(Figure 2C). Therefore, the presence of the Sec9 binding
domain at the C terminus appears to be critical for its
ability to restore both growth and secretory function
within the cell.
To determine whether the gain of secretory function
by the chimeras involved a restoration of the interaction
with Sec9, we performed coimmunoprecipitation as-
says on strains containing each of the chimeras. Sro7,
Current Biology
1138Figure 2. Rescue of the Cold-Sensitive Phenotype and the Post-Golgi Secretory Defect of the sro7D,sro77D Double Mutant by the Mlgl/
Sro7 Chimera
(A) Expression of chimeric proteins in S. cerevisiae. Yeast extracts from an sro7D,sro77D strain expressing the indicated genes from a low-
(CEN) or high-copy (2) plasmid were immunoblotted with antibodies against the C and N terminus of Sro7, Mlgl-1, or actin. The expression
levels of proteins in relation to CEN-SRO7 are indicated.
(B) The Mlgl/Sro7 chimera can rescue the cold sensitivity of an sro7D,sro77D strain. Chimeras were expressed in an sro7D,sro77D strain from
a low- or high-copy plasmid, and the different strains were tested for growth at permissive (37°C) and restrictive temperature (17°C) on YPD
media (1% Bacto yeast extract, 2% Bacto peptone, and 2% glucose).
(C) Analysis of Bgl2 protein distribution in the sro7D,sro77D mutant expressing M/S or S/M chimera. The percentage of the total Bgl2 that is
found internally in different strains grown at 37°C or shifted to 19°C for 3 hr is depicted graphically. The data represent the average of three
independent experiments.
(D) Mlgl/Sro7 chimera interacts specifically with the t-SNARE Sec9 in vivo. SEC9 was expressed from a multicopy plasmid in an sro7D,sro77D
strain containing either SRO7 on a low-copy vector or Mlgl-1, M/S, and S/M on high-copy vectors. Lysates from each strain were subjected
to immunoprecipitation with either saturating amounts of affinity-purified antibodies to Sec9 or an equivalent amount of IgG purified from
preimmune (PI) sera of the same rabbit. The immune complexes were captured, washed, and analyzed by blotting with α-Sro7, α-Mlgl-1, and
α-Sec9 antibodies.
(E) Quantitation of the coimmunoprecipitation efficiencies with a Storm PhosphorImager with ImageQuant software. The values are expressed
as the amount of coimmunoprecipitating proteins present as a percentage of the total protein in the lysate.Mlgl-1, and the two chimeric proteins were expressed T
bin the sro7D,sro77D genetic background, so that the
plasmid-encoded proteins were the only source of n
pSro7/77 in the yeast cells. Detergent lysates were pre-
pared from each strain and subjected to immunopreci- b
mpitation with purified antiserum raised against Sec9. We
monitored the presence of each protein in the immuno- m
precipitation by Western blotting with antibodies against
Sec9, Sro7 (C terminus), or Mlgl-1. The results shown D
ain Figures 2D and 2E demonstrate that Sro7 and the
M/S chimera clearly associated with Sec9 in cell ly- i
tsates, whereas Mlgl-1 and the S/M chimera did not.hese data provide the first direct evidence that SNARE
inding is likely to be a critical and conserved compo-
ent of the in vivo function of the Sro7/Lgl family of
roteins. Furthermore, we demonstrate that SNARE
inding capacity of two highly divergent Lgl family
embers is dependent on amino acid sequence deter-
inants localized within their C-terminal domain.
Recently, Mlgl-1 has been shown to complement the
. melanogaster Lgl mutant defect when expressed as
transgene [5]. In order to determine whether the abil-
ty to interact with Syntaxin 4 was also conserved be-
ween mouse and fly Lgl isoforms, we examined the
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1139ability of full-length and C-terminal domains of Mlgl-1
and Lgl proteins to interact with GST-Syntaxin 4 in vitro.
As can be seen in Figure S1 (see the Supplemental Data
available with this article online), we find that Drosoph-
ila Lgl has retained the ability to specifically bind Syn-
taxin 4, although to a slightly lesser degree than that of
the cognate Mlgl-1 protein. Interestingly, the C-terminal
domains of both of these proteins interact with Syn-
taxin 4 at a level similar to that of the full-length protein.
Therefore, the ability of the C termini of Lgl family mem-
bers to bind t-SNAREs is a highly conserved property
of this family of proteins.
Interaction of Sro7 and Sro7/Mlgl Chimeras
with Type II and Type V Myosins
In order to identify additional binding partners of Sro7
within the yeast cell, we performed a proteomic analy-
sis of the major proteins that coassociated with a Pro-
tein A-Sro7 fusion protein. We found three major pro-
teins that were specifically enriched in the high-salt
elution of Protein A-Sro7 by MALDI-TOF mass spec-
trometry analysis of proteolyzed gel slices (Figure 3A).
The most abundant was identified as the 150 kd precur-
sor of the LA viral coat protein—a common contami-
nant in IgG-Protein A purifications from yeast. The next
two abundant proteins were unambiguously identifiedFigure 3. Characterization of Myosin V and Myosin II Interactions with Sro7/Lgl Chimeras
(A) Isolation of Sro7-associated proteins from yeast lysates. Protein-A-tagged Sro7 was isolated by affinity binding to IgG Sepharose from
native yeast detergent extracts. Beads were washed, and associated proteins were eluted with a 0.2–1.5 M salt gradient. The marked bands
were identified by mass spectrometry analysis of trypsin-digested gel slices.
(B) Immunoblot analysis of proteins specifically associated with ProtA/Sro7 beads and absent from control IgG Sepharose beads incubated
with a lysate containing an untagged form of Sro7.
(C) Coimmunoprecipitation of Sro7 and Myo2 from detergent extracts of wild-type yeast containing single-copy Sro7 and Myo2. Identical
exposures are shown for each immunoblot.
(D) Coimmunoprecipitation of Mlgl-1 and M/S or S/M chimeric proteins with α-Myo2 and α-Myo1 from detergent extracts of sro7D,sro77D
strains expressing Mlgl-1, M/S, or S/M on high-copy vectors. Quantitation of the efficiency of coprecipitations demonstrated approximately
1%–2% of the total Mlgl-1, M/S, or S/M chimera associated with the Myo2 immunoprecipitations.as the t-SNARE Sec9 and the type V myosin, Myo2,
which is involved in the polarized delivery of post-Golgi
vesicles. The identity and specificity of these proteins
were confirmed by immunoblot analysis of IgG beads
before and after the salt elution along with IgG beads
incubated with a control lysate lacking Protein A-Sro7
(Figure 3B). We also confirmed the coassociation of
Myo2 with Sro7 by reciprocal coimmunoprecipitation
analysis from wild-type cells expressing only endoge-
nous Sro7 and Myo2 (Figure 3C). This identifies a novel
interaction between Sro7 and the yeast type V myosin,
Myo2. With use of recombinant proteins, the interaction
between Sro7 and Myo2 was found to be direct and
mapped to the neck region of Myo2 (G.R., unpublished
data). Whereas full-length Sro7 binds avidly to recombi-
nant GST-Myo2 neck protein, the Sro7 C-terminal do-
main failed to show detectable interaction, suggesting
that the N-terminal WD domain is required for this in-
teraction (Figure S2). Kagami et al. [6] have previously
suggested a physical interaction between the yeast
Type II myosin, Myo1, and Sro7; however, we were un-
able to detect Myo1 in any of the samples shown in
Figures 3A–3C. We were, however, able to detect a
weak association between Sro7/Lgl proteins and Myo1
in Myo1 immunoprecipitations (see below).
To determine whether the loss of myosin II or myosin
Current Biology
1140Figure 4. Distribution of Polarity and Secre-
tion Markers Cdc42, Sec4, Sec15, and Myo2
Is Unaffected in sro7D,sro77D Cells at Both
Permissive and Restrictive Temperatures
(A) Wild-type (WT) and sro7D,sro77D cells
were grown at 37°C or shifted to 19°C for
3 hr before fixation and then processed for
fluorescence microscopy. Visualization of
the polarity-establishment protein Cdc42,
the Rab GTPase Sec4, the exocyst subunit
Sec15, and the vesicle-transport motor
Myo2 was performed with specific purified
antibodies.
(B) Quantitation of polarized markers in WT
and sro7D,sro77D cells. Cells were scored
for polarized localization of the various
markers at the emerging bud sites, bud tips,
or mother-daughter neck regions. A mini-
mum of 200 cells were counted for each ex-
periment.V binding could account for the functional differences m
dwe see in the S/M versus M/S chimeras, we examined
ethe ability of each of these proteins and Mlgl-1 to be
tcoprecipitated by antibodies directed against yeast
oMyo1 or Myo2 proteins. As observed in Figure 3D, Mlgl-1
tand both S/M and M/S chimeras could clearly associ-
cate with Myo2 and weakly with Myo1 immunoprecipi-
States. Therefore, the ability to interact with either of
ethese myosins appears to be highly conserved; how-
oever, these interactions cannot account for the func-
otional differences seen in these chimeras. The dramatic
cfunctional and SNARE-interaction difference seen with
athe M/S and S/M chimeras provides strong evidence
pthat the ability to interact with the SNARE protein is
Wcritical to the in vivo function of Sro7.
s
i
The Localization of Actin-Dependent Secretory r
and Polarity Markers Is Unaffected t
in sro7D,sro77D Cells t
We have previously demonstrated that actin polarity is 3
not detectably altered under conditions in which we a
see a dramatic defect in secretory function in sro7D, [
sro77D cells [1]. Recently, it has been suggested that s
the exocytic defects observed in sro7D,sro77D cellsight arise as a secondary effect of actin-polarization
efects [7]. To determine whether there was a subtle
ffect, not previously detected in sro7D,sro77D, on ac-
in polarity, we examined the localization of a number
f proteins whose polarity is known to be highly sensi-
ive to perturbations in actin polarity/integrity. These in-
lude the markers of polarized growth in yeast: Cdc42,
ec4, Sec15, and Myo2. The localization of these mark-
rs is sensitive to both the integrity of actin cables and
ngoing secretion [8, 9]. We examined the localization
f Cdc42, Sec4, Sec15, and Myo2 in wild-type cells and
ells that lack functional copies of Sro7 and Sro77 with
ffinity-purified antibodies against each protein at both
ermissive (37°C) and restrictive temperature (19°C).
e observed that in sro7D,sro77D mutant cells, the
taining pattern for all four proteins examined was sim-
lar to wild-type cells before and after a 3 hr shift to the
estrictive temperature (Figure 4). This finding is consis-
ent with our previous observation that the actin cy-
oskeleton organization in this mutant is normal after a
hr downshift, although a dramatic effect on growth
nd secretion is clearly evident under these conditions
1]. Moreover, because Myo2 polarization is normal in
ro7D,sro77D cells, this finding demonstrates that the
interaction of Myo2 and Sro7 is not required for Myo2
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1141localization. Importantly, it reaffirms that the secretory
defect associated with sro7D,sro77D cells is not an in-
direct result of an actin depolarization. In contrast, we
believe that the actin-polarity defects observed by Aro-
nov et al. [7] are likely to be an effect of growing the
yeast cells at 25°C—a semirestrictive temperature for
this mutant—prior to the low-temperature shift.
Conclusion
Two major models for the function of the Sro7/Lgl fam-
ily of proteins have been proposed. The first model sug-
gests that Sro7/Lgl proteins work to regulate cell-
surface polarity through modulation of acto-myosin
function [6, 10, 11]. Critical to this model is the observa-
tion of a conserved interaction of Lgl family proteins
with type II myosins. We have suggested a second, dis-
tinct but not mutually exclusive model, in which the ac-
tion of Sro7/Lgl proteins is directed at regulation of ves-
icle transport to the cell surface. Each of these models
is based, in part, on the physical association of Sro7/
Lgl protein with a specific candidate effector. In this
paper, we have generated the first direct test of the im-
portance of the interaction of an Lgl family protein with
a specific effector. Here, we confirm that Sro7 interacts
with the t-SNARE Sec9 and also describe a novel and
conserved interaction with a yeast Type V myosin,
Myo2. Most importantly, we find that the ability of Sro7
to bind to the yeast t-SNARE Sec9 appears to be criti-
cal to the ability of Lgl chimeric proteins to functionally
rescue the growth and secretion defects associated
with loss of Sro7/77. The observed interaction of Myo2
with Sro7 was also observed between Myo2 and
Mlgl-1, as well as both the Sro7/Mlgl chimeras. This
interaction, therefore, cannot account for the functional
differences seen between the chimeras. Consistent
with the notion that Lgl proteins act in vesicle transport,
we find that the interaction of the C-terminal domain of
Lgl family members with SNAREs appears to be a
highly conserved property of all the members of this
family, including the Drosophila tumor suppressor Lgl—
although the native SNARE partner in flies has not yet
been identified. Taken together, these findings provide
strong evidence that the ability to bind t-SNAREs is a
crucial component of the functional architecture of Lgl
proteins. In yeast, it is clear that loss of this protein
leads to dramatic but not complete loss of secretory
function. Likewise in mammals and flies, Lgl function
may be restricted to the delivery of a distinct class of
membrane vesicles, perhaps containing other key cell-
fate determinants. Furthermore, the interaction with
type V myosins (and perhaps type II myosins) may play
a role either in movement of these specific vesicles or
perhaps in the polarization of the Lgl protein itself on
the plasma membrane. Future work will no doubt help
to elucidate the details of how these conserved interac-
tions are mechanistically tied to the function of Lgl pro-
teins in cell polarity.
Experimental Procedures
Purification of the Recombinant Proteins
GST fusion proteins were prepared as described previously [12].
See the Supplemental Experimental Procedures for the protocol
used for purification of full-length Sec9.In Vitro Transcription-Translation
Amplified DNA was added directly to reticulocyte lysate-coupled in
vitro transcription-translation system (TNT T7 Quick for PCR DNA,
Promega) in the presence of [35S]methionine and processed as de-
scribed by the manufacturer.
Binding Assays
Binding assays were done as described previously [1]. See the
Supplemental Experimental Procedures for details.
Identification of Sro7-Associated Proteins
Identification of the major proteins associated with Protein-A-
tagged Sro7 was as described in the Supplemental Experimental
Procedures.
Native Immunoprecipitations
Native coimmunoprecipitations were performed as described pre-
viously [1] with affinity-purified antibodies to Sec9 and Sro7. De-
tailed protocol for immunoprecipitations of chimeras with α-Myo1
and α-Myo2 is described in the Supplemental Experimental Pro-
cedures.
Bgl2-Secretion Assay
Exoglucanase Bgl2 secretion was tested essentially as described
previously [3].
Construction of Chimeras
Chimeric molecules were constructed by overlapping PCR and ver-
ified by sequencing [13, 14]. Mgl-1 cDNA was amplified from re-
verse-transcribed total mouse Kidney RNA, and sequence analysis
demonstrated a perfect match to the published sequence (Gen-
bank accession number NM_008502). Primers and templates used
are described in Table S1.
Supplemental Data
Detailed Experimental Procedures, as well as several supplemental
figures and tables, are available at http://www.current-biology.com/
cgi/content/full/15/12/1136/DC1/.
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